Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Forge Therapeutics

Forge Therapeutics
2015 FOUNDED
PRIVATE STATUS
Grant LATEST DEAL TYPE
$11.1M LATEST DEAL AMOUNT
13 INVESTORS
Description

Developer of an innovative drug discovery platform designed to offer novel antibiotics to treat multi-drug resistant bacteria. The company's platform develops small molecule inhibitors targeting metalloenzymes using gram-negative bacteria, enabling healthcare professionals to access various biochemical processes and biological catalysis.to treat diseases.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
  • 10578 Science Center Drive
  • Suite 205
  • San Diego, CA 92121
  • United States
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Forge Therapeutics’s full profile, request a free trial.

Forge Therapeutics Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Grant 03-Jan-2019 $11.1M 000.00 Completed Generating Revenue
3. Early Stage VC (Series A) 01-Dec-2017 000.00 000.00 Completed Generating Revenue
2. Grant 26-Jul-2016 $8.8M Completed Generating Revenue
1. Accelerator/Incubator 01-Jan-2015 Completed Generating Revenue
To view this company’s complete deal history including valuation and funding, request access »

Forge Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series A 0,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
To view this company’s complete Cap Table, request access »

Forge Therapeutics Competitors (9)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
SelectX Pharmaceuticals Venture Capital-Backed Boston, MA 00 000.00 00000000000 000.00
00000 000000000000 Formerly VC-backed Cambridge, MA 00 00000 000000000 00000
000000000 Accelerator/Incubator Backed Basel, Switzerland 0 00.000 0000000000 00.000
000000 00000000000 Formerly VC-backed San Jose, CA 00 000.00 000000000 000.00
00000000 Formerly VC-backed South San Francisco, CA 00 00000 0000000000.
To view this company’s complete list of competitors, request access »

Forge Therapeutics Investors (13)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Alexandria Venture Investments Corporate Venture Capital Minority 000 0000 000000 0
Evotec Corporation Minority 000 0000 000000 0
Keiretsu Capital Venture Capital Minority 000 0000 000000 0
MagnaSci Ventures Venture Capital Minority 000 0000 000000 0
MP Healthcare Venture Management Corporate Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 13 investors. Get the full list »

Forge Therapeutics Executive Team (5)

Name Title Board
Seat
Contact
Info
Zachary Zimmerman Ph.D Co-Founder, Chief Executive Officer & Board Memberg
Esther van den Boom Chief Financial Officer
David Puerta Ph.D Co-Founder, Chief Operating Officer & Vice President of Discovery
Seth Cohen Ph.D Scientific Co-Founder & Advisor

1 Former Executive

You’re viewing 4 of 5 executives. Get the full list »

Forge Therapeutics Board Members (7)

Name Representing Role Since Contact
Info
Brian Dorsey Self Board Member 000 0000
Jeffrey Moore Ph.D MP Healthcare Venture Management Board Member 000 0000
John Schmid Self Board Member 000 0000
Jonathan Kabakoff Alexandria Venture Investments Board Observer 000 0000
Mario Polywka Ph.D Evotec Board Member 000 0000
You’re viewing 5 of 7 board members. Get the full list »